CME/CE
Continuing education certificates / evaluation form
You will receive an email with a link to the evaluation form. The survey will close on Dec. 31, 2022—please complete prior to the closing date.
Planning committee
| Name | Title | Organization |
|---|---|---|
| David Skolnick, MD | Physician | Saint Luke’s |
| Jennifer Sauer | Administrative Assistant | Saint Luke’s |
| Michael Nassif, MD | Physician | Saint Luke’s |
| Christina Hoffman | Marketing Director Client Services | Saint Luke’s |
| Taylor Anderson | Marketing and Public Relations Manager | Saint Luke’s |
| Diane Cunningham | Advanced Practice Provider | Saint Luke’s |
| Janet Lipke | Advanced Practice Provider | Saint Luke’s |
| Sarah Heavey, APP | Advanced Practice Provider | Saint Luke’s |
| Angela Postma, APP | Advanced Practice Provider | Saint Luke’s |
| Marci Ebberts, RN | Clinical Education Specialist | Saint Luke’s |
| Chip Hayes | Pharmacist | Saint Luke’s |
| Fred Loper, MD | INMED Review Committee Chair | INMED |
Accreditation statements
Physician
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Missouri State Medical Association through the joint providership of Institute for International Medicine (INMED) and Saint Luke’s Health System.
The Institute for International Medicine is accredited by the Missouri State Medical Association to provide continuing medical education for physicians. Institute for International Medicine designates this Other Activity (Live Activity and Enduring Material) for a maximum of 15.5 AMA PRA Category 1 Credit(s) TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AAFP has reviewed Dr. Robert D. Conn Heart Conference and deemed it acceptable for up to 15.00 Live AAFP Prescribed credits. Term of Approval is from 12/01/2022 to 12/02/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nursing
Saint Luke’s Health System is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
15.5 contact hours
Planning Committee Disclosures
David Skolnick, MD – Abbott and Medtronic: Speaker – All relevant financial relationships have been mitigated
Taylor Anderson – No relevant financial relationships
Diane Cunningham, RN, FNP-BC – No relevant financial relationships
Marci Ebberts, APRN, FNP-C, CCRN-K – No relevant financial relationships
Charles Hayes, III, PharmD, BCCP – No relevant financial relationships
Sarah Heavey, APP – No relevant financial relationships
Christina Hoffman, BS – No relevant financial relationships
Janet Lipke, RN, ANP-BC – No relevant financial relationships
Fred Loper, MD – No relevant financial relationships
Michael Nassif, MD – Astra Zeneca, Boehringer Ingelheim: Grant/Research; Vifor, Impulse Dynamics: Consultant – All relevant financial relationships have been mitigated
Angela Postma, APRN, AGNP-C – No relevant financial relationships
Jennifer Sauer – No relevant financial relationships
Faculty Disclosures:
C. Noel Bairy Merz, MD – iRhythm: Stock; SHL Telemedicine: Consultant – All relevant financial relationships have been mitigated
George Bakris, MD – Bayer, Vifor, Ionis, Alnylam, AstraZeneca, Janssen, Quantum, Genomics, Novo Nordisk: Consultant/Research – All relevant financial relationships have been mitigated
Javed Butler, MD, MPH, MBA – Abbott, Adrenomed, Amgen, Array, AstraZeneca, Bayer, Boehringer, Bristol Myers Squibb, CVRx, G3 Pharma, Innolife, Impulse Dynamics, Janssen, LivaNova, Luitpold, Merck, Medtronic, Novartis, Novo Nordisk, Roche, Vifor: Consultant – All relevant financial relationships have been mitigated
Kevin Bybee, MD – No relevant financial relationships
Adnan Chhatriwalla, MD – Boston Scientific: Research Grant; Edwards Lifescience, Medtronic: Proctor; Abbott Vascular, Medtronic, Edwards LIfescience: Speaker – All relevant financial relationships have been mitigated
Zachary Cox, PharmD – Cumberland Pharmaceuticals, AstraZeneca: Research Funding – All relevant financial relationships have been mitigated
Marci Ebberts, APRN, FNP-C, CCRN-K – No relevant financial relationships
James Fang, MD, FACC, FAHA, FHFSA – Johnson & Johnson, AstraZeneca, Amgen, Boehringer-Ingelheim, Novartis, Abbott: Research/Consultant – All relevant financial relationships have been mitigated
Bernard Gersh, MB, Ch.B., D.Phil. – No relevant financial relationships
Sanjaya Gupta, MD, MBA – Boston Scientific, Respicardia: Consultant; Medtronic: Consultant/Research – All relevant financial relationships have been mitigated
Chetan Huded, MD, MSc – Abbott, Missouri ACC, SCAI: Research Funding; Boston Scientific: Consultant – All relevant financial relationships have been mitigated
Dany Jacob, MD – No relevant financial relationships
Jessica Kline, DO – No relevant financial relationships
Mikhail Kosiborod, MD, FACC, FAHA – Alnylam, AstraZeneca, Amgen, Bayer, Boehringer Ingelheim, Cytokinetics, Esperionm, Eli Lilly, Janssen Lexicon, Merck, Pharmacosmos, Pfizer, Novo Nordisk, Sanofi, Vifor: Consultant; AstraZenwca, Boehringer Ingelheim: Research Grant Support – All relevant financial relationships have been mitigated
Daniel Kramer, MD, MPH – Heartcor: Consultant (Core Lab Reviewer); US Food and Drug Administration: Consultant – All relevant financial relationships have been mitigated
Kyle Lehenbauer, MD – No relevant financial relationships
Kathryn Lindley, MD – No relevant financial relationships
Donald Lloyd-Jones, MD, ScM – NIH, CMS, AHA: Grant Funding; American Heart Association: Unpaid Fiduciary Officer – All relevant financial relationships have been mitigated
Sean McCarney, MD – No relevant financial relationships
Michael Nassif, MD – Astra Zeneca, Boehringer Ingelheim: Grant/Research; Vifor, Impulse Dynamics: Consultant – All relevant financial relationships have been mitigated
Dan Nguyen, MD – No relevant financial relationships
James O’Keefe, MD – Amgen, AstraZeneca, Boehringer Ingelheim Pharma, Janssen, Lilly: Speaker’s Bureau; Cardio Tabs: CMO/Founder/Ownership – All relevant financial relationships have been mitigated
Graham Pollock, MD – No relevant financial relationships
Andrew Sauer, MD – Abbott: Speaking/Consulting; General Prognostics, Boston Scientific, Story Health, and Bodyport: Consulting/Research – All relevant financial relationships have been mitigated
John Saxon, MD – No relevant financial relationships
Kristin Sollars, MSN, RN, CCRN – No relevant financial relationships
Brett Sperry, MD – Alnylam & BridgeBio/Eidos: Consulting; Pfizer: Speaking/Consulting – All relevant financial relationships have been mitigated
Daniel Steinhaus, MD – Boston Scientific, Medtronic: Speaker – All relevant financial relationships have been mitigated
Randall Thompson, MD – No relevant financial relationships
Rafael Torosyan, MD – No relevant financial relationships
Stefanie Vamenta, MD – No relevant financial relationships
Alan Wimmer, MD – Boston Scientific: Research/Speaker; Atricure, SentreHeart, Biosense Webster, & Medtronic: Research – All relevant financial relationships have been mitigated